VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
09 avr. 2019 08h00 HE
|
VBI Vaccines, Inc.
Poster presentation to highlight data from three previously-conducted clinical studies of Sci-B-Vac®, VBI’s prophylactic Hepatitis B vaccineIn all three studies, seroprotection rates of more than 98%...